RecruitingNot ApplicableNCT07389967

Nutrition Awareness Among Women With Non-Metastatic Breast Cancer


Sponsor

UNC Lineberger Comprehensive Cancer Center

Enrollment

200 participants

Start Date

Jan 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study explores perspectives of women with non-metastatic breast cancer regarding their willingness and ability to make dietary changes pertaining to foods/food products that may pose a risk to their cancer prognosis and survival. This is a single-group study conducted entirely online. All study activities, including consent, educational brochure and surveys, will be completed remotely. Participants will receive email invitations to complete questionnaires in REDCap. Questionnaire 1 will collect sociodemographic information (no PHI) and a brief dietary recall. Questionnaire 2 will assess identification of ultra-processed foods. Before Questionnaire 3, participants will review a two-page educational flyer explaining the link between diet, obesity, and cancer, with information on unhealthy calories and food processing. Questionnaire 3 will assess participants' willingness and ability to eat healthier foods and reduce unhealthy foods. At study completion, participants will receive a thank-you message and a brief satisfaction survey.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria6

  • Age \>18 -Female
  • Diagnosis of non-metastatic breast cancer
  • Completion of primary treatment for breast cancer
  • No recurrence or metastasis; or no other cancer other than basal or squamous cell
  • Willingness to provide a private email address for all study activities
  • Ability to read and understand English

Interventions

BEHAVIORALEducational Brochure

The two-page educational brochure is emailed to participants after Questionnaire 2 and before they begin Questionnaire 3.


Locations(1)

UNC Cancer Hospital

Chapel Hill, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07389967


Related Trials